- Home
- OCUL vs AGO Comparison
OCUL vs AGO Comparison
Compare OCUL & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCUL | AGO |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.1B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | OCUL | AGO |
|---|---|---|
| Price | $11.41 | $84.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | $22.56 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 4.6M | 340.7K |
| Earning Date | 03-02-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.00 |
| Revenue | $55,783,000.00 | ★ $911,000,000.00 |
| Revenue This Year | N/A | $4.22 |
| Revenue Next Year | $11.96 | N/A |
| P/E Ratio | ★ N/A | $10.63 |
| Revenue Growth | N/A | ★ 5.08 |
| 52 Week Low | $5.79 | $74.09 |
| 52 Week High | $16.44 | $96.50 |
Technical Indicators
Market Signals| Indicator | OCUL | AGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 28.01 |
| Support Level | $10.77 | $84.65 |
| Resistance Level | $13.03 | $86.18 |
| Average True Range (ATR) | 0.77 | 1.51 |
| MACD | -0.04 | -0.74 |
| Stochastic Oscillator | 48.37 | 1.78 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.